EUVIMEDEUVIMED entdecken
Crossref

Refining cause of death attribution among opioid, opioid‐stimulant and stimulant acute toxicity deaths

Yi-Shin Grace Chang iD, Nora Anderson, Kyna Long, Ciaran Murphy, Vanessa M McMahan iD, Luke N Rodda iD, Alex H Kral iD, Phillip O Coffin iD

Addiction · 2026-02 · 121 (2) · 288-294

DOI: 10.1111/add.70190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction, online erschienen am 17.09.2025. Verfasst von Yi-Shin Grace Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Fentanyl, Analgesics, Opioid, Central Nervous System Stimulants, Drug Overdose. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: NIDA NIH HHS, NCIPC CDC HHS, CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Deaths attributed to a combination of opioids and stimulants have risen dramatically in recent years, largely attributed to fentanyl, yet little is understood about which drug class is primarily responsible. Attributing death to acute substance toxicity is complex and lacks clear standards. We aimed to determine whether additional causes of death and other significant conditions among deaths attributed to fentanyl were similar regardless of stimulant involvement, and distinct from deaths involving stimulants without opioids.

Design

Cross‐sectional analysis using records from the California Electronic Death Registration System. Setting and cases Unintentional acute toxicity deaths involving fentanyl or stimulants (methamphetamine or cocaine) occurring in San Francisco, USA, during 2013–2023.

Measurements

We compared demographic characteristics and causes of death or other significant conditions (cardiovascular, cerebrovascular, other medical cause, or no other additional cause) among five mutually exclusive groups of deaths: stimulants without opioids (stimulant‐only), fentanyl with stimulants (fentanyl‐stimulant), fentanyl without stimulants (fentanyl‐only), other opioids (e.g., heroin, oxycodone) with stimulants (“other opioid‐stimulant”), and other opioids without stimulants (“other opioids‐only”). We conducted separate unadjusted and adjusted multivariable logistic regression models for each outcome (cardiovascular, cerebrovascular, other medical, or no additional cause). The primary analysis included results for the fentanyl groups.

Findings

Of 4475 deaths attributed to acute opioid and/or stimulant toxicity, 24% involved stimulants‐only, 45% fentanyl‐stimulants, and 12% fentanyl‐only; the remaining 20% involved other opioids. Stimulant‐only decedents were the oldest (mean age 54 years), followed by fentanyl‐stimulant (47 years) and fentanyl‐only (44 years; p < 0.001 for all). The adjusted odds of having cardiovascular, cerebrovascular, or other medical causes of death (adjusted odds ratios [aORs] from 0.03 to 0.52, with 95% confidence intervals [CIs] from 0.01 to 0.68) were lower and the odds of no additional cause of death (aORs from 2.53 to 3.31, with 95% CIs from 2.00 to 3.40) were higher for both groups of deaths involving fentanyl compared with deaths attributed to stimulants‐only. There were no statistically significant differences in causes of death when comparing fentanyl‐only with fentanyl‐stimulant deaths. Findings were similar for other opioid deaths.

Conclusion

In San Francisco, USA, causes of death and other significant condition characteristics among deaths attributed to fentanyl appear to be similar regardless of the involvement of stimulants, but are markedly different from deaths involving stimulants without opioids. When reporting on drug‐related mortality and developing interventions, deaths attributed to a combination of fentanyl and stimulants may be appropriately considered in the context of opioid overdose prevention, while deaths attributed to stimulants without opioids may require a response focused on preventing and treating underlying chronic medical conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FentanylAnalgesics, OpioidCentral Nervous System StimulantsDrug OverdoseMethamphetamineCocaineHumansMaleFemaleCross-Sectional StudiesAdultCause of DeathMiddle AgedSan FranciscoYoung AdultAdolescentAged

Stichwörter der Autor:innen

acute toxicitycocainefentanylmethamphetamineopioid overdoseopioid‐stimulantstimulant

Substanzen

FentanylAnalgesics, OpioidCentral Nervous System StimulantsMethamphetamineCocaine

Autor:innen und Institutionen

  • Center on Substance Use and Health, San Francisco Department of Public Health, San Francisco, CA, USA.
  • Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Office of the Chief Medical Examiner, San Francisco, CA, USA.
  • Urban Health Program, RTI International, San Francisco, CA, USA.

ORCID-Profile: Yi-Shin Grace Chang, Vanessa M McMahan, Luke N Rodda, Alex H Kral, Phillip O Coffin

Förderung

  • NIDA NIH HHS
  • NCIPC CDC HHS
  • CDC HHS
  • National Institute on Drug Abuse

Zitieren

APA

Chang, Y. G., Anderson, N., Long, K., Murphy, C., McMahan, V. M., Rodda, L. N., Kral, A. H., & Coffin, P. O. (2026). Refining cause of death attribution among opioid, opioid‐stimulant and stimulant acute toxicity deaths. Addiction, 121(2), 288-294. https://doi.org/10.1111/add.70190

Vancouver

Chang YG, Anderson N, Long K, Murphy C, McMahan VM, Rodda LN, et al. Refining cause of death attribution among opioid, opioid‐stimulant and stimulant acute toxicity deaths. Addiction. 2026;121(2):288-294. doi:10.1111/add.70190

BibTeX
@article{Chang2026,
  author = {Chang, Yi-Shin Grace and Anderson, Nora and Long, Kyna and Murphy, Ciaran and McMahan, Vanessa M and Rodda, Luke N and Kral, Alex H and Coffin, Phillip O},
  title = {Refining cause of death attribution among opioid, opioid‐stimulant and stimulant acute toxicity deaths},
  journal = {Addiction},
  year = {2026},
  volume = {121},
  number = {2},
  pages = {288--294},
  doi = {10.1111/add.70190}
}
Kostenlos starten →